Polymer-drug conjugates containing antimalarial drugs and antibiotics

被引:21
作者
Alven, S. [1 ]
Aderibigbe, B. A. [1 ]
Balogun, M. O. [2 ]
Matshe, W. M. R. [2 ]
Ray, S. S. [3 ]
机构
[1] Univ Ft Hare, Dept Chem, Alice Campus, ZA-5700 Alice, Eastern Cape, South Africa
[2] CSIR Mat Sci & Mfg, Polymer & Composites, Pretoria, South Africa
[3] Univ Johannesburg, Dept Appl Chem, ZA-2028 Johannesburg, South Africa
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
Antimalarials; Combination therapy; Polymer-drug conjugates; Primaquine; Sulfadoxine; Pyrimethamine; 4-Aminosalicylic acid; PLASMODIUM-FALCIPARUM; IN-VITRO; COMBINATION THERAPY; AZITHROMYCIN; ARTESUNATE; PRIMAQUINE; MALARIA; DESIGN;
D O I
10.1016/j.jddst.2019.101171
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most of the currently used antimalarial drugs suffer from drug resistance, poor bioavailability and biodegradability, drug toxicity and poor water solubility. To overcome some of the aforementioned limitations, combination therapy involving the combination of two or more antimalarials is currently used. Malaria is also treated by combining selected antibiotics with antimalarials resulting in good treatment outcomes. In this research, the aforementioned approach was employed by developing polymer-drug conjugates incorporated with antimalarials and antibiotics for a synergistic effect. The successful incorporation of antimalarials and antibiotics onto the polyaspartamide-based conjugates was confirmed by H-1 NMR, FTIR and SEM. The XRD spectrums displayed the amorphous nature of the conjugates and indicated the absence of free drugs. The antiplasmodial evaluation of the conjugates further revealed their antimalarial activity against the asexual stage of the parasite with a % inhibition in the range of 35.6-99.9 at 1 mu M, and 55.4-100.8 at 5 mu M which was either comparable or better than the free drugs. The incorporation of the antibiotics together with the antimalarials into the polymer revealed a synergistic effect indicating that antibiotics act as a potentiating agent. However, more research is needed to confirm these findings.
引用
收藏
页数:12
相关论文
共 49 条
[1]  
Abioye Amos O., 2016, Pharmaceutical Nanotechnology, V4, P38, DOI 10.2174/2211738504666160213001714
[2]   Synthesis, characterization and in vitro analysis of polymer-based conjugates containing dihydrofolate reductase inhibitors [J].
Aderibigbe, B. A. ;
Mhlwatika, Z. ;
Nwamadi, M. ;
Balogun, M. O. ;
Matshe, W. M. R. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 50 :388-401
[3]   Preparation, characterization and in vitro release kinetics of polyaspartamide-based conjugates containing antimalarial and anticancer agents for combination therapy [J].
Aderibigbe, B. A. ;
Ray, Suprakas Sinha .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2016, 36 :34-45
[4]   Synthesis and characterization of polyamidoamine conjugates of neridronic acid [J].
Aderibigbe, B. A. ;
Sadiku, E. R. ;
Ray, S. Sinha ;
Mbianda, X. Y. ;
Fotsing, M. C. ;
Agwuncha, S. C. ;
Owonubi, S. J. .
POLYMER BULLETIN, 2015, 72 (03) :417-439
[5]   EVALUATION OF CIPROFLOXACIN EFFECT ON THE ANTIMALARIAL ACTIVITY OF SOME ANTIMALARIAL DRUGS IN PLASMODIUM BERGHEI INFECTED MICE [J].
Ayogu, E. E. ;
Ugwuowo, O. ;
Amorha, K. C. ;
Okonta, J. M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (05) :1896-1903
[6]  
Bell D. J., 2008, PLOS PATHOG, V3, P1
[7]   Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic [J].
Blasco, Benjamin ;
Leroy, Didier ;
Fidock, David A. .
NATURE MEDICINE, 2017, 23 (08) :917-928
[8]  
Castelli F., 2012, MEDITERR J HEMATOL I, V4, P1
[9]   Multiple antibiotics exert delayed effects against the Plasmodium falciparum anicoplast [J].
Dahl, Erica L. ;
Rosenthal, Philip J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) :3485-3490
[10]   Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy [J].
Dragojevic, Sonja ;
Ryu, Jung Su ;
Raucher, Drazen .
MOLECULES, 2015, 20 (12) :21750-21769